Protection of adenovirus from neutralizing antibody by cationic PEG derivative ionically linked to adenovirus

References

• HaismaHJBelluARPharmacological interventions for improving adenovirus usage in gene therapyMol Pharm201181505520979428
   PubMed Web of Science ®Google Scholar
• MatthewsQLCapsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approachMol Pharm20118131121047139
   PubMed Web of Science ®Google Scholar
• RenteriaSSClemensCCCroyleMADevelopment of a nasal adenovirus-based vaccine: Effect of concentration and formulation on adenovirus stability and infectious titer during actuation from two delivery devicesVaccine20102892137214820044048
   PubMed Web of Science ®Google Scholar
• Gene therapy clinical trials worldwide [database on the Internet]J Gene Med Available from: http://www.wiley.com//legacy/wileychi/genmed/clinical/Accessed January 25, 2011
   Google Scholar
• HorowitzJAdenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applicationsCurr Opin Mol Ther19991450050911713766
   PubMedGoogle Scholar
• MaGShimadaHHiroshimaKTadaYSuzukiNTagawaMGene medicine for cancer treatment: commercially available medicine and accumulated clinical data in ChinaDrug Des Devel Ther20092115122
   PubMedGoogle Scholar
• SinghRKostarelosKDesigner adenoviruses for nanomedicine and nanodiagnosticsTrends Biotechnol200927422022919251331
   PubMed Web of Science ®Google Scholar
• WuTLErtlHCImmune barriers to successful gene therapyTrends Mol Med2009151323919101205
   PubMed Web of Science ®Google Scholar
• ZaissAKMachadoHBHerschmanHRThe influence of innate and pre-existing immunity on adenovirus therapyJ Cell Biochem2009108477879019711370
   PubMed Web of Science ®Google Scholar
• ZhongZHanJWanYZhangZSunXAnionic liposomes enhance and prolong adenovirus-mediated gene expression in airway epithelia in vitro and in vivoMol Pharm20118367368221510701
   PubMed Web of Science ®Google Scholar
• SunCZhangYFengLEpidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, southern ChinaVaccine201129223837384121447314
   PubMed Web of Science ®Google Scholar
• MastTCKiersteadLGuptaSBInternational epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type- 36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trialsVaccine201028495095719925902
   PubMed Web of Science ®Google Scholar
• PilankattaRChawlaTKhannaNSwaminathanSThe prevalence of antibodies to adenovirus serotype 5 in an adult Indian population and implications for adenovirus vector vaccinesJ Med Virol201082340741420087930
   PubMed Web of Science ®Google Scholar
• SinghRTianBKostarelosKArtificial envelopment of nonenveloped viruses: enhancing adenovirus tumor targeting in vivoFASEB J20082293389340218556649
   PubMed Web of Science ®Google Scholar
• EtoYYoshiokaYIshidaTOptimized PEGylated adenovirus vector reduces the anti-vector humoral immune response against adenovirus and induces a therapeutic effect against metastatic lung cancerBiol Pharm Bull20103391540154420823571
   PubMed Web of Science ®Google Scholar
• MokHPalmerDJNgPBarryMAEvaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responsesMol Ther2005111667915585407
   PubMed Web of Science ®Google Scholar
• EtoYGaoJQSekiguchiFNeutralizing antibody evasion ability of adenovirus vector induced by the bioconjugation of methoxypolyethylene glycol succinimidyl propionate (MPEG-SPA)Biol Pharm Bull200427693693815187452
   PubMed Web of Science ®Google Scholar
• CroyleMAChirmuleNZhangYWilsonJM“Stealth” adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lungJ Virol200175104792480111312351
   PubMed Web of Science ®Google Scholar
• KimPHSohnJHChoiJWActive targeting and safety profile of PEG-modified adenovirus conjugated with herceptinBiomaterials20113292314232621227505
   PubMed Web of Science ®Google Scholar
• LeeGKMaheshriNKasparBSchafferDVPEG conjugation moderately protects adeno-associated viral vectors against antibody neutralizationBiotechnol Bioeng2005921243415937953
   PubMed Web of Science ®Google Scholar
• O’RiordanCRLachapelleADelgadoCPEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivoHum Gene Ther19991081349135810365665
   PubMed Web of Science ®Google Scholar
• EtoYYoshiokaYMukaiYOkadaNNakagawaSDevelopment of PEGylated adenovirus vector with targeting ligandInt J Pharm20083541–23817904316
   PubMed Web of Science ®Google Scholar
• JungYParkHJKimPHRetargeting of adenoviral gene delivery via Herceptin-PEG-adenovirus conjugates to breast cancer cellsJ Control Release2007123216417117854941
   PubMed Web of Science ®Google Scholar
• Suzuki-KouyamaEKatayamaKSakuraiFHexon-specific PEGylated adenovirus vectors utilizing avidin-biotin interactionBiomaterials20113261724173021106235
   PubMed Web of Science ®Google Scholar
• WortmannAVöhringerSEnglerTFully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodiesMol Ther200816115416217848961
   PubMed Web of Science ®Google Scholar
• WangIJJhuangMCChenYHYehLKLiuCYYoungTHChitosan modification of adenovirus to modify transfection efficiency in bovine corneal epithelial cellsPLoS One201058e1208520711466
   PubMed Web of Science ®Google Scholar
• FasbenderAZabnerJChillónMComplexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivoJ Biol Chem199727210647964899045673
   PubMed Web of Science ®Google Scholar
• SteelJCCavanaghHMBurtonMADingwallDJKalleWHModification of liposomal concentration in liposome/adenoviral complexes allows significant protection of adenoviral vectors from neutralising antibody, in vitroJ Virol Methods20051261–2313615847916
   PubMed Web of Science ®Google Scholar
• DoddsEPiperTAMurphySJDicksonGCationic lipids and polymers are able to enhance adenoviral infection of cultured mouse myotubesJ Neurochem19997252105211210217291
   PubMed Web of Science ®Google Scholar
• MoselhyJSarkarSChiaMCEvaluation of copolymers of N-isopropylacrylamide and 2-dimethyl(aminoethyl)methacrylate in nonviral and adenoviral vectors for gene delivery to nasopharyngeal carcinomaInt J Nanomedicine20072346147818019844
   PubMed Web of Science ®Google Scholar
• LvHZhangSWangBCuiSYanJToxicity of cationic lipids and cationic polymers in gene deliveryJ Control Release2006114110010916831482
   PubMed Web of Science ®Google Scholar
• AhnCHChaeSYBaeYHKimSWSynthesis of biodegradable multi-block copolymers of poly(L-lysine) and poly(ethylene glycol) as a non-viral gene carrierJ Control Release200497356757415212887
   PubMed Web of Science ®Google Scholar
• LiangBHeMLXiaoZPSynthesis and characterization of folate- PEG-grafted-hyperbranched-PEI for tumor-targeted gene deliveryBiochem Biophys Res Commun2008367487488018201560
   PubMed Web of Science ®Google Scholar
• LaiWFLinMCNucleic acid delivery with chitosan and its derivativesJ Control Release2009134315816819100795
   PubMed Web of Science ®Google Scholar
• EtoYGaoJQSekiguchiFPEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion abilityJ Gene Med20057560461215543536
   PubMed Web of Science ®Google Scholar
• YamashitaMInoAKawabataKSakuraiFMizuguchiHExpression of coxsackie and adenovirus receptor reduces the lung metastatic potential of murine tumor cellsInt J Cancer200712181690169617546646
   PubMed Web of Science ®Google Scholar
• KimJSLeeSHChoYSChoiJJKimYHLeeJHEnhancement of the adenoviral sensitivity of human ovarian cancer cells by transient expression of coxsackievirus and adenovirus receptor (CAR)Gynecol Oncol200285226026511972385
   PubMed Web of Science ®Google Scholar
• KoyamaYItoTMatsumotoHNovel poly(ethylene glycol) derivatives with carboxylic acid pendant groups: synthesis and their protection and enhancing effect on non-viral gene transfection systemsJ Biomater Sci Polym Ed200314651553112901435
   PubMed Web of Science ®Google Scholar
• HanSMahatoRISungYKKimSWDevelopment of biomaterials for gene therapyMol Ther20002430231711020345
   PubMed Web of Science ®Google Scholar
• FisherKDSeymourLWHPMA copolymers for masking and retargeting of therapeutic virusesAdv Drug Deliv Rev201062224024520005911
   PubMed Web of Science ®Google Scholar
• SubrVKostkaLSelby-MilicTCoating of adenovirus type 5 with polymers containing quaternary amines prevents binding to blood componentsJ Control Release2009135215215819166885
   PubMed Web of Science ®Google Scholar
• HofherrSEMokHGushikenFCLopezJABarryMAPolyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopeniaHum Gene Ther200718983784817767399
   PubMed Web of Science ®Google Scholar
• DoroninKShashkovaEVMaySMHofherrSEBarryMAChemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirusHum Gene Ther200920997598819469693
   PubMed Web of Science ®Google Scholar
• HofherrSEShashkovaEVWeaverEAKhareRBarryMAModification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expressionMol Ther20081671276128218461056
   PubMed Web of Science ®Google Scholar
• KimP-HKimTIYockmanJWKimSWYunCOThe effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapyBiomaterials20103171865187419962189
   PubMed Web of Science ®Google Scholar
• HanJZhaoDZhongZZhangZGongTSunXCombination of adenovirus and cross-linked low molecular weight PEI improves efficiency of gene transductionNanotechnology20102110105106
   Web of Science ®Google Scholar
• KasmanLMBaruaSLuPRegeKVoelkel-JohnsonCPolymer-enhanced adenoviral transduction of CAR-negative bladder cancer cellsMol Pharm2009651612161919655763
   PubMed Web of Science ®Google Scholar
• KelkarSAPfisterKKCrystalRGLeopoldPLCytoplasmic dynein mediates adenovirus binding to microtubulesJ Virol20047818101221013215331745
   PubMed Web of Science ®Google Scholar
• MorralNO’NealWKRiceKLethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboonsHum Gene Ther200213114315411779418
   PubMed Web of Science ®Google Scholar
• Medina-KauweLKEndocytosis of adenovirus and adenovirus capsid proteinsAdv Drug Deliv Rev200355111485149614597142
   PubMed Web of Science ®Google Scholar
• MeierOGreberUFAdenovirus endocytosisJ Gene Med20046Suppl 1S15216314978758
   PubMed Web of Science ®Google Scholar
• DavisHEMorganJRYarmushMLPolybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranesBiophys Chem2002972–315917212050007
   PubMed Web of Science ®Google Scholar
• CarlisleRCDiYCernyAMHuman erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1Blood200911391909191819131551
   PubMed Web of Science ®Google Scholar
• DavisHERosinskiMMorganJRYarmushMLCharged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregationBiophys J20048621234124214747357
   PubMed Web of Science ®Google Scholar
• YuanFDellianMFukumuraDVascular permeability in a human tumor xenograft: molecular size dependence and cutoff sizeCancer Res19955517375237567641188
   PubMed Web of Science ®Google Scholar
• FisherKDGreenNKHaleASubrVUlbrichKSeymourLWPassive tumour targeting of polymer-coated adenovirus for cancer gene therapyJ Drug Target2007157–854655117671901
   PubMed Web of Science ®Google Scholar
• GodbeyWTWuKKMikosAGPoly(ethylenimine) and its role in gene deliveryJ Control Release1999602–314916010425321
   PubMed Web of Science ®Google Scholar
• WeissSISieverlingNNiclasenMUronic acids functionalized polyethyleneimine (PEI)-polyethyleneglycol (PEG)-graft-copolymers as novel synthetic gene carriersBiomaterials200627102302231216337267
   PubMed Web of Science ®Google Scholar
• ParkJWMokHParkTGPhysical adsorption of PEG grafted and blocked poly-L-lysine copolymers on adenovirus surface for enhanced gene transductionJ Control Release2010142223824419913577
   PubMed Web of Science ®Google Scholar
• GreenNKHerbertCWHaleSJExtended plasma circulation time and decreased toxicity of polymer-coated adenovirusGene Ther200411161256126315215884
   PubMed Web of Science ®Google Scholar